Ads
related to: AstraZeneca
Search results
Tempus Announces Expansion of Collaboration with AstraZeneca to Leverage Tempus Next to Support...
Morningstar· 2 days agoTempus, a leader in artificial intelligence and precision medicine, today announces an expansion of its collaboration with AstraZeneca, which leverages Tempus Next to arm ...
Chasing Merck, AstraZeneca's PCSK9 inhibitor lowers cholesterol in phase 1 test
FierceBiotech· 5 days agoAstraZeneca’s small molecule lowered levels of “bad” cholesterol by more than half in patients who...
New antibiotic based on AstraZeneca drugs kills off deadly bacteria, spares the good guys
FierceBiotech· 3 days agoA new antibiotic based on drugs developed by AstraZeneca can kill off dangerous bacteria that cause...
Journey to the center of the mirth
Politico· 4 days agoLet’s get into it. In today’s edition: → A military who’s who strutted around an airport-adjacent convention center. → First in Playbook: A pandemic vaccine contract inked with AstraZeneca ...
Cramer's Lighting Round: ‘You've got a winner' with Astra Zeneca
NBC Los Angeles· 2 days ago“Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to...
Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZeneca
WROC Rochester· 4 days agoAs of the close of business on April...
AstraZeneca started at buy at Goldman, which rates GSK a neutral
Morningstar· 4 days agoGoldman Sachs started coverage of AstraZeneca at buy as it rated rival pharmaceutical company GSK a neutral. Analysts led by Rajan Sharma said AstraZeneca
Cancer-fighting antibodies inject chemo directly into tumor cells, upping effectiveness
NBC NEWS· 20 hours agoThe chemotherapy-antibody combinations, known as antibody drug conjugates, have been described as...
Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug
Benzinga· 5 days agoTuesday, the FDA approved Amgen Inc AMGN Bkemv (eculizumab-aeeb) as the first interchangeable...
Cellectis Reports Financial Results for First Quarter 2024
Morningstar· 5 days ago• Cellectis announced completion of the additional equity investment of $140M by AstraZeneca • Cash position of $143 million as of March 31, 20241; cash runway projection ...